Targeted Antibody Mogamulizumab Superior to Vorinostat for Previously Treated CTCL
Youn H. Kim • 10 Dec 2017
Resminostat maintenance for advanced cutaneous lymphoma: RESMAIN study
Rudolf Stadler • 1 Oct 2018
Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.